1. Introduction {#sec1}
===============

Coronaviruses are enveloped, positive-sense, single-stranded RNA viruses that belong to the *Coronaviridae* family. Coronaviruses infect a wide range of animal species including humans, causing a diverse array of diseases but each coronavirus tends to be species-specific. Coronaviruses are subdivided into four genera, alpha, beta, gamma and delta-coronaviruses, based on phylogenetic clustering ([@bib1]). Feline, ferret and mink coronaviruses belong to the alphacoronaviruses genus and typically cause self-limiting diarrheal disease in cats, ferrets and minks, respectively. Ferrets and minks are members of the family Mustelidae that includes carnivorous mammals such as badgers, weasels, otters and wolverines. Ferrets are presumed to have been domesticated for more than two thousand years ([@bib46]), and over the years ferrets have become more popular as pets. They are also widely used as a small animal model in the study of some human viral infections, such as influenza A virus ([@bib5]) and Severe Acute Respiratory Syndrome (SARS) coronavirus ([@bib18]).

Epizootic catarrhal enteritis (ECE) was first described in 1993 in domestic ferrets in the eastern part of the US ([@bib48]) and subsequently reported in domestic and laboratory ferrets in the US, EU and Japan ([@bib30]; [@bib43]; [@bib45]). The causative agent of ECE is ferret coronavirus ([@bib48]; [@bib50]). ECE is characterized by lethargy, vomiting, inappetence and green mucous diarrhea, and older ferrets are more severely affected by ECE than young ferrets.

Minks are closely related to ferret and there are two mink species, European minks and American minks. The European minks have become a critically endangered species, and American minks are raised on farms mainly for their fur or live in the wild. Mink epizootic catarrhal gastroenteritis (ECG) is caused by mink coronavirus and the clinical signs of ECG resemble those of ECE with anorexia, mucoid diarrhea and decreased pelt quality. Minks over four months of age are mostly affected by ECG. Since the first description of ECG in minks in 1975 ([@bib29]), ECG has been reported in the US and the EU ([@bib16]; [@bib19]; [@bib47]).

The morbidity of these coronavirus diarrheal diseases in ferrets and minks is high but mortality is generally low unless the infected animals have concurrent illnesses, such as Aleutian disease ([@bib16]). Interestingly, a systemic disease associated with ferret coronavirus has appeared in 2002 in the US and the EU and subsequently in Asia ([@bib3]; [@bib14]; [@bib15]; [@bib32]; [@bib45]). Ferrets affected with this novel ferret systemic coronavirus disease (FSCV) exhibit weight loss, diarrhea, anorexia and granulomatous lesions in various organs and occasional neurological signs, which indicate that a quite different disease pathogenesis is involved in this progressively fatal disease ([@bib14]; [@bib15]). This recently emerged FSCV in ferrets resembles feline infectious peritonitis (FIP), a fatal systemic disease in cats. Similar to ferret and mink coronavirus infections, feline coronavirus typically causes self-limiting diarrhea and is quite common among cats especially in high-density environments with high morbidity and low mortality \[reviewed in ([@bib38])\]. However, a small number of cats infected with feline coronavirus develop FIP ([@bib14]; [@bib17]; [@bib32]; [@bib37]; [@bib49]). The mechanism responsible for the transition from enteric viral infection to FIP is not fully understood, but the prevailing hypothesis is that viral tropism change from the intestinal enterocytes to macrophages and the inadequate cellular immunity to eliminate the mutated viruses are the major contributors to FIP development in individual cats ([@bib4]; [@bib6]; [@bib31]; [@bib40], [@bib41]).

Although these coronaviruses are important pathogens for animals, no effective vaccine or treatment is yet available. Thus, development of effective treatment options for these coronavirus infections is expected to provide significant benefits to these animals. Moreover, effective antiviral therapeutics that combats multiple coronaviruses would provide considerable benefits since substantial resources are needed for antiviral drug development. Coronaviruses encode two viral proteases, 3C-like protease (3CLpro) and papain-like protease, which process viral polyproteins into mature proteins. Due to the essential nature of viral proteases in virus replication, efforts have been made to identify inhibitors that target these viral proteases of important human and animal coronaviruses ([@bib2]; [@bib8]; [@bib10]; [@bib20]; [@bib24], [@bib25], [@bib26]; [@bib28]; [@bib51]). However, most of the research on coronavirus protease inhibitors has focused on SARS coronavirus, and relatively few reports are available for animal coronaviruses.

We have previously reported the antiviral effects of 3CLpro inhibitors against animal and human coronaviruses including SARS coronavirus, Middle East Respiratory Syndrome (MERS) coronavirus, murine and feline coronaviruses ([@bib11]; [@bib25]; [@bib35]; [@bib39]; [@bib42]). We have also showed the *in vivo* effects of 3CLpro inhibitors in mice with murine coronavirus infection ([@bib26]), and more recently in laboratory cats with FIP ([@bib23]) and client-owned cats with naturally occurring FIP ([@bib39]).

In this study, we investigated the structure-activity relationships of a focused library of 3CLpro inhibitors for their effects against the 3CLpro of ferret and mink coronaviruses. Using the fluorescence resonance energy transfer (FRET) assay, we identified potent inhibitors against 3CLpro of ferret and mink coronaviruses with 50% inhibitory concentrations (IC~50~) of the low or sub-micromolar range. A multiple alignment analysis of 3CLpro of ferret and mink coronaviruses was conducted, and three-dimensional homology models of ferret and mink coronavirus 3CLpro were constructed and compared with the crystal structure of feline coronavirus 3CLpro to study the structural basis for the activity of 3CLpro inhibitors.

2. Materials and method {#sec2}
=======================

2.1. Compounds {#sec2.1}
--------------

Synthesis of NPI52 ([@bib42]), GC376 ([@bib24]), GC551 and GC543 ([@bib33]), GC523 ([@bib34]), GC583, GC587, GC591 and GC597 ([@bib13]), GC772 and GC774 ([@bib12]) were previously described. The compound list is shown in [Table 1](#tbl1){ref-type="table"} .Table 1Compound structures and activity of the compounds against 3CLpro of ferret, mink and feline coronaviruses in the FRET assay.Table 1CompoundR~1~ (Cap)R~2~R~3~R~4~ (war head)IC~50~ (μM)[a](#tbl1fna){ref-type="table-fn"}Feline CoVFerret CoVMink CoVGC376(C~6~H~5~)CH~2~O(C000000000000 000000000000 000000000000 111111111111 000000000000 111111111111 000000000000 000000000000 000000000000O)NHLeu (Isobutyl)CH(OH)SO~3~Na0.49 ± 0.071.33 ± 0.191.44 ± 0.38GC523(CO)CONH cyclohexyl1.41 ± 0.240.83 ± 0.411.95 ± 0.40GC543Cha(Cyclohexyl methyl)CHO0.69 ± 0.131.45 ± 0.301.55 ± 0.24GC551CH(OH)SO~3~Na0.42 ± 0.081.04 ± 0.280.86 ± 0.28GC583m-Cl(C~6~H~4~)CH~2~CHO0.63 ± 0.150.98 ± 0.361.61 ± 0.42GC587CH(OH)SO~3~Na0.15 ± 0.030.29 ± 0.080.59 ± 0.12GC591(CO)CONH Cyclopropyl6.57 ± 1.43\>50\>40GC597LeuCHO0.88 ± 0.181.45 ± 0.181.64 ± 0.30GC772m-Cl(C~6~H~4~)SO~2~NHChaCHO10.68 ± 1.179.16 ± 1.727.26 ± 1.57GC774p-Cl(C~6~H~4~)SO~2~NH10.08 ± 1.6224.19 ± 6.9921.45 ± 8.91[^3]

2.2. Cell and virus {#sec2.2}
-------------------

Crandell-Rees feline kidney cells (CRFK) and a feline coronavirus (FIPV-1146) were purchased from American Type Culture Collection (Manassas, VA). Feline coronavirus was grown with Eagle\'s Minimal Essential Medium (MEM) supplemented with 5% fetal bovine serum, 100 U/ml penicillin and 100 μg/ml streptomycin in CRFK cells.

2.3. Expression and purification of 3CLpro of ferret and mink coronaviruses {#sec2.3}
---------------------------------------------------------------------------

The codon-optimized cDNAs encoding the full length of 3CLpro of ferret coronavirus NL-2010 (GenBank accession number: [KM347965.1](ncbi-n:KM347965.1){#intref0010}) and mink coronavirus WD1133 (GenBank accession number: [HM245926.1](ncbi-n:HM245926.1){#intref0015}) with the nucleotides for 6 His residues at the N-terminus were synthesized by Integrated DNA Technologies (Coralville, IA). Each synthesized gene was subcloned into the pET28(+) vector (Addgene, Cambridge, MA). Each 3CLpro was expressed and purified following the standard procedures previously described by our group ([@bib24], [@bib23]). Briefly, the vector was transformed into *Escherichia coli* BL21 cells (Invitrogen, Carlsbad, CA) and each protein was expressed in Luria Bertani broth by induction with 1mM isopropyl β-D-thiogalactopyranoside for 4--6 h at 37 °C in a shaking incubator. The harvested cells were centrifuged, and the supernatants were subject to Ni-NTA affinity columns (QI-AGEN, Valencia, CA) for purification of 3CLpro. The purified 3CLpro were stored at −80 °C until use. The cloning and expression of feline coronavirus 3CLpro was previously reported ([@bib23]).

2.4. FRET assay {#sec2.4}
---------------

The FRET-based assays for ferret and mink coronavirus 3CLpros were developed following the procedures previously described ([@bib7]). First, the activity of the recombinant ferret 3CLpro and mink coronavirus 3CLpro, as well as feline coronavirus 3CLpro, was confirmed in the FRET assay. The substrate used in the FRET assay is 5-FAM-SAVLQSGK-QXL520-NH2. Serial dilutions of each 3CLpro were prepared in 25 μl of assay buffer (120 mM NaCl, 4mM Dithiothreitol, 50 mM HEPES, 30% Glycerol at pH 6.0). Then each dilution was mixed with 25 μl of assay buffer containing the substrate and the mixture was added to a black 96 well imaging microplate (Fisher Scientific, Waltham, MA). The plate was incubated at 37 °C and serial fluorescence readings were measured at up to 90 min on a fluorescence microplate reader (FLx800, Biotek, Winnooski, VT) at an excitation and an emission wavelength of 485 nm and 516 nm, respectively. The percentage activity progress was calculated for each 3CLpro compared to the activity at 90 min.

After confirmation of the activity of 3CLpro, the inhibitory effect of each compound on the activity of 3CLpro was determined as previously described ([@bib7]; [@bib24]). Serial dilutions of each compound stock (10 mM) were prepared in DMSO prior to the assay. Each compound dilution was added to 3CLpro in 25 μl of assay buffer. Following incubation at 37 °C for 30 min, the mixture was added to a black 96 well imaging microplate containing substrate in 25 μl of assay buffer. Following the incubation of the plate at 37 °C for 30 min, fluorescence readings were measured on a fluorescence microplate reader. Relative fluorescence was calculated by subtracting background fluorescence from raw fluorescence values ([@bib7]; [@bib24]). The 50% inhibitory concentration (IC~50~), which is the concentration of a compound that reduces fluorescence by half in the FRET assay, was calculated for each compound using non-linear regression analysis (four parameter variable slope) in GraphPad Prism software version 6.07 (GraphPad Software, La Jolla, CA).

2.5. Multiple amino acid sequence alignment of feline, ferret and mink coronavirus 3CLpros {#sec2.5}
------------------------------------------------------------------------------------------

The amino acid sequences of 3CLpro of ferret coronaviruses from Netherlands (GenBank accession number: [KM347965.1](ncbi-n:KM347965.1){#intref0020}), the US (GenBank accession numbers: [KX512809.1](ncbi-n:KX512809.1){#intref0025} and [KX512810.1](ncbi-n:KX512810.1){#intref0030}) and Japan (GenBank accession numbers: LC119077.1 and LC215871.1), and the amino acid sequences of 3CLpro of mink coronaviruses from the US. (GenBank accession numbers: [HM245925.1](ncbi-n:HM245925.1){#intref0035} and [HM245926.1](ncbi-n:HM245926.1){#intref0040}) and China (GenBank accession number: [MF113046.1](ncbi-n:MF113046.1){#intref0045}) were aligned using Clustal Omega (<https://www.ebi.ac.uk/Tools/msa/clustalo/>) ([@bib36]). Forty strains of feline coronaviruses whose full 3CLpro sequences are available in the GenBank were also included in the multiple sequence alignment. The 3CLpro of transmissible gastroenteritis virus (TGEV), a porcine coronavirus (GenBank accession number: [ABG89303.1](ncbi-p:ABG89303.1){#intref0055}), has a high amino acid homology with feline coronavirus 3CLpro (92.05--93.71%), and the crystal structure of GC376 bound with TGEV 3CLpro was previously reported by our group ([@bib24]). Therefore, TGEV 3CLpro was included as a reference.

2.6. Antiviral effects of compounds in cell culture {#sec2.6}
---------------------------------------------------

A stock solution of each compound (10 mM) was prepared in DMSO and serial dilutions of compound were prepared in medium. Mock (medium only) or each compound dilution was added to confluent CRFK cells in 12 or 24 well plates, and the cells were immediately inoculated with feline coronavirus at a multiplicity of infection (MOI) of 0.05. The virus infected cells were then incubated at 37 °C for up to 36 h until extensive cytopathic effects (CPE) appeared. Following repeated freezing and thawing of the cells, virus titers were determined. Briefly, ten-fold serial dilutions of each well were added to confluent CRFK cells in 96 well plates, and the 96 well plates were incubated at 37 °C until no further CPE was observed. The 50% tissue culture infective dose (TCID~50~) was then calculated by the standard TCID~50~ method ([@bib44]). The 50% effective concentration (EC~50~) is the concentration of a compound that reduces virus titers by half in cell culture. The EC~50~ of each compound was calculated using non-linear regression analysis (four parameter variable slope) in GraphPad Prism software version 6.07 (GraphPad Software, La Jolla, CA).

2.7. Nonspecific cytotoxic effect {#sec2.7}
---------------------------------

To assess the cytotoxicity of each compound, semi-confluent CRFK cells grown in 24-well plates were incubated with a compound at various concentrations up to 150 μM at 37° for 36 h. Cell cytotoxicity was measured by CytoTox 96 nonradioactive cytotoxicity assay kit following the manufacturer\'s protocol (Promega, Madison, WI), and the 50% cytotoxic concentration (CC~50~) of each compound was determined using non-linear regression analysis (four parameter variable slope) in GraphPad Prism software. The *in-vitro* therapeutic index (CC~50~/EC~50~) of each compound was also calculated for feline coronavirus.

2.8. Three-dimensional structural modelling of ferret and mink coronavirus 3CLpros {#sec2.8}
----------------------------------------------------------------------------------

Three-dimensional structures of ferret and mink coronavirus 3CLpros were built using the I-TASSER server (<https://zhanglab.ccmb.med.umich.edu/I-TASSER/>) ([@bib52]). These ferret and mink coronavirus 3CLpro models have a C-score of 2, estimated TM-score of 0.99 ± 0.04 and estimated root-mean-square deviation (RMSD) of 2.3 ± 1.8 Å. The constructed ferret and mink coronavirus 3CLpro models were superposed with the crystal structure of TGEV 3CLpro (PDB accession number: [4F49](pdb:4F49){#intref0065}) or feline coronavirus 3CLpro (PDB accession number: 4ZRO9) using the PyMol molecular graphics system, Version 1.8 (Schrodinger LLC, Cambridge, MA) ([@bib9]).

3. Results {#sec3}
==========

3.1. Effects of compounds against 3CLpro of ferret and mink coronaviruses in the FRET assay {#sec3.1}
-------------------------------------------------------------------------------------------

The activities of the recombinant ferret and mink coronavirus 3CLpros were determined and compared to that of feline coronavirus 3CLpro prior to the inhibition assay. The activity of each 3CLpro gradually increased over time, following a similar trend with that of feline coronavirus 3CLpro, confirming the activity of ferret and mink coronavirus 3CLpros ([Fig. 1](#fig1){ref-type="fig"} ).Fig. 1Activities of the recombinant ferret, mink and feline coronavirus 3CLpros in the FRET assay. Each expressed 3CLpro was added to assay buffer containing a fluorogenic substrate. The mixture was then incubated at 37 °C and fluorescence readings were measured at various time intervals up to 90 min of incubation. The percentage activity progress was calculated for each 3CLpro compared to the activity at 90 min, and the progress curve was plotted against time.Fig. 1

We then evaluated the inhibitory activity of the compounds with variations on R groups against each 3CLpro. The chemical structures of the compounds and their IC~50~ values are listed in [Table 1](#tbl1){ref-type="table"}. GC376 was previously shown to be effective in cats with experimental or naturally-occurring FIP ([@bib23]; [@bib39]). Therefore, GC376 was included as a reference compound. The IC~50~ values of GC376 against ferret and mink coronavirus 3CLpro were determined at 1.33 and 1.44 μM, respectively, moderately higher than the IC~50~ of 0.49 μM against feline coronavirus 3CLpro. A warhead is a reactive functional group on a compound, which interacts with the cysteine residue in the active site of 3CLpro. When the bisulfite adduct warhead \[CH(OH)SO~3~Na\] at R4 on GC376 was replaced with an α-ketoamide warhead, (CO)CONHcyclohexyl (GC523), the activity was moderately decreased against feline coronavirus 3CLpro, but less pronounced changes in activity were observed against ferret and mink coronavirus 3CLpros. Replacement of Leu (isobutyl) at R3 in GC376 with Cha (cyclohexyl methyl) (GC551) did not change the activity against feline coronavirus 3CLpro and only slightly increased the activity against ferret and mink coronavirus 3CLpros. This result suggest that Leu and Cha are functionally interchangeable for all three 3CLpros. The similar effect of Leu and Cha at R3 position against these coronavirus 3CLpros was also demonstrated by GC583 and GC597. The substitution of a benzyl group (C~6~H~5~) at R1 with m-Chloro benzyl group in compounds with a bisulfide adduct warhead (GC551 and GC587) resulted in increased activities against all three 3CLpros. The bisulfite adduct at R4 (GC551 and GC587) resulted in increased activities compared to aldehyde counterparts (GC543 and GC583) against all three 3CLpros. The replacement of aldehyde or bisulfite adduct at R4 in GC583 or GC587, respectively, with (CO)CONHcyclopropyl (GC591) led to remarkably decreased activity against all 3CLpros (\>40-fold increases of IC~50~ values). The replacement of O(CO)NH at R2 in GC583 with a sulfonamide linkage (SO~2~NH) (GC772) led to a substantial decrease in activity against all 3CLpros. The replacement of m-Chloro benzyl group at R1 in GC772 with p-Chloro benzyl (GC774) did not affect the activity against feline coronavirus 3CLpro, but further decreased the activity against ferret and mink coronavirus 3CLpros.

These IC~50~ results indicate that the structural requirements of ferret, mink and feline coronavirus 3CLpros are similar, although ferret and mink coronavirus 3CLpros seem to share more similar structural requirements. The most potent 3CLpro against all 3CLpro was GC587 with IC~50~ values of 0.15, 0.29 and 0.59 μM for feline, ferret and mink coronavirus 3CLpro, respectively.

3.2. Antiviral activity of the compounds against feline coronavirus replication in cell culture and cytotoxicity of the compounds {#sec3.2}
---------------------------------------------------------------------------------------------------------------------------------

Since ferret and mink coronaviruses do not grow in cell culture, we examined the antiviral effects of the compounds against feline coronavirus to assess their effects in cell culture. The anti-feline coronavirus activity of these compounds has not been reported except for GC376, GC543 and GC551 ([@bib24], [@bib25], [@bib26]). The EC~50~ values of the compounds ranged between 0.02 and 0.55 μM ([Table 2](#tbl2){ref-type="table"} ), revealing that all compounds are cell-permeable and strongly inhibit the replication of feline coronavirus in cell culture. Overall, the antiviral effects of the tested compounds are in line with the results from the FRET assay, which confirms the findings of structure-activity relationship. No substantial cytotoxicity was observed for all compounds with CC~50~ values ranging between 115.57 ∼ \>150 μM ([Table 2](#tbl2){ref-type="table"}). The *in vitro* therapeutic indices (CC~50/~EC~50~) for the compounds ranged between 272.7 ∼ \>7500 ([Table 2](#tbl2){ref-type="table"}). These results indicate that these compounds have a wide safety margin *in vitro*.Table 2Anti-feline coronavirus activity and cytotoxicity of the compounds in cell culture.Table 2CompoundGC376GC523GC543GC551GC583GC587GC591GC597GC772GC774EC~50~ (μM)[a](#tbl2fna){ref-type="table-fn"}0.05 ± 0.040.07 ± 0.020.07 ± 0.060.02 ± 0.060.09 ± 0.010.05 ± 0.020.55 ± 0.230.04 ± 0.010.36 ± 0.120.39 ± 0.03CC~50~ (μM)\>150\>150\>150\>150115.6 ± 0.5138.2 ± 6.64\>150\>150\>150\>150T.I\>3000\>2143\>2143\>750012842764\>273\>3750\>417\>385[^4]

3.3. Multiple amino acid sequence alignment of 3CLpro of ferret, mink and feline coronaviruses {#sec3.3}
----------------------------------------------------------------------------------------------

The homology of 3CLpro amino acid sequences among virus strains within each coronavirus is high, ranging 97.02--100% for ferret coronaviruses, 97.68--98.68% for mink coronaviruses and 95.7--100% for feline coronaviruses. The 3CLpro amino acid sequence homology between ferret and mink coronaviruses (83.44--86.09) is higher than that between ferret and feline coronaviruses (74.17--77.81%) or between mink and feline coronaviruses (71.52--73.51%), suggesting a closer relationship between ferret and mink coronaviruses. Regardless of some variations in the 3CLpro sequences among these coronaviruses, the catalytic residues and their locations (41H and 144C) are conserved across feline, ferret and mink coronaviruses ([Fig. 2](#fig2){ref-type="fig"} ).Fig. 2Multiple sequence alignments of 3CLpro of ferret, mink and feline coronaviruses. Transmissible gastroenteritis virus (TGEV) Miller strain 3CLpro sequence was also included for comparative purposes. FIPV-1146 is a feline coronavirus; FRCoV-NL-2010, FRCoV-4370, Ferret-063, FECV1 and FSCV6 are ferret coronaviruses; WD1127, WD1333 and Mink/China/1/2016 are mink coronaviruses. The catalytic residues (H41 and C144) are in red boxes. The residues of TGEV 3CLpro that interact with GC376 are shown in blue boxes. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)Fig. 2

Furthermore, residues T47, F139, H162, H163 and E165 are conserved in all coronavirus strains ([Fig. 2](#fig2){ref-type="fig"}). These residues were previously identified to engage in hydrogen bonding or hydrophobic interactions with GC376 in the X-ray co-crystallography structure of TGEV 3CLpro-GC376 ([@bib24]). TGEV (Miller strain) 3CLpro shares a high amino acid sequence homology with that of feline coronavirus 3CLpro (92.05--93.71%). Reflecting the highly conserved 3CLpro between these viruses, GC376 was previously shown to have potent and comparable inhibitory activity against both feline coronavirus and TGEV in cell culture and against their 3CLpros in the FRET assay ([@bib24]).

3.4. Three-dimensional homology structural models for 3CLpro of ferret and mink coronaviruses {#sec3.4}
---------------------------------------------------------------------------------------------

The homology-based 3CLpro structural models of ferret and mink coronaviruses superposed with a crystal structure of feline coronavirus 3CLpro are shown in [Fig. 3](#fig3){ref-type="fig"} A. The RMSD for 124 superposed Cα atoms of residues 41--165 that contain the catalytic residues and the residues interacting with GC376 is 0.441 Å between feline and ferret coronavirus 3CLpros, 0.418 Å between feline and mink coronavirus 3CLpros, and 0.268 Å between ferret 3CLpro and mink coronavirus 3CLpros. These results suggest that feline, ferret and mink coronavirus 3CLpros closely resemble one another and that ferret and mink coronavirus 3CLpros align even more closely with each other. Superposition of the crystal structures of TGEV and feline coronavirus 3CLpros revealed an overall distance of 0.415 Å RMSD for 124 superposed Cα atoms between residues 41--165, which shows high structural homology between feline coronavirus and TGEV 3CLpros ([Fig. 3](#fig3){ref-type="fig"}B). The catalytic residues, H41 and C144, and the residues potentially interacting with GC376 based on the TGEV 3CLpro-GC376 complex crystal structure were found to be closely aligned in feline, ferret and mink coronavirus 3CLpros ([Fig. 4](#fig4){ref-type="fig"} ).Fig. 3Three-dimensional homology structure models of ferret and mink coronavirus 3CLpros. A. Ferret coronavirus and mink coronavirus 3CLpros were modelled using I-TASSER ([@bib52]) and superposed with a crystal structure of feline coronavirus 3CLpro (PDB ID: [4ZRO](pdb:4ZRO){#intref0075}). B. Crystal structures of feline coronavirus 3CLpro (PDB ID: [4ZRO](pdb:4ZRO){#intref0080}) and TGEV (PDB ID: [4F40](pdb:4F40){#intref0085}) were superposed. The crystal structure of TGEV-GC376 complex was previously reported by us ([@bib24]). GC376, indicated as red stick, is shown in the active site of the superposed 3CLpro. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)Fig. 3Fig. 4The superposed residues in the catalytic site of feline, ferret and mink coronavirus 3CLpros. A yellow stick represents GC376. The catalytic residues, H41 and C144, are shown in red. The five residues that interact with GC376 in the crystal structure of TGEV-GC376 complex are shown in various colors. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)Fig. 4

4. Discussion {#sec4}
=============

Coronaviruses are a diverse family of viruses that infect animals and humans. However, the overall structure and function of 3CLpro are conserved among coronaviruses, which suggests that development of protease inhibitors broadly active against multiple coronaviruses may be feasible. A number of studies have been published on coronavirus 3CLpro inhibitors but previous reports have largely focused on SARS-coronavirus ([@bib10]; [@bib21]; [@bib27]) and more recently on MERS-coronavirus, and only a few studies are available on 3CLpro inhibitors for multiple coronaviruses. The 3CLpro inhibitors that are active against two or more coronaviruses have been reported by our and other groups ([@bib24], [@bib23]; [@bib42]) (reviewed in ([@bib20]). We have previously shown that GC376, a reversible inhibitor of 3CLpro, is efficacious in treating cats with experimental ([@bib23]) or naturally-occurring FIP ([@bib39]). This inhibitor is also active against human and animal coronaviruses and other viruses that encode 3C protease or 3CLpro *in vitro*, including viruses in the *Caliciviridae* or *Picornaviridae* families ([@bib24], [@bib26], [@bib23]). In this study, we evaluated the activity of a focused library of 3CLpro inhibitors including GC376 against ferret and mink coronavirus 3CLpros, as well as feline coronavirus 3CLpro, to investigate the relationship between structure and activity of these inhibitors for these viruses.

Our structure-activity relationship study using the FRET assay showed that, in general, the tested compounds have similar activities against feline, ferret and mink coronavirus 3CLpros. In prior reports, we demonstrated that R3 variations (Leu or Cha) in our dipeptidyl compound series significantly affect the activity against human norovirus 3CLpro ([@bib13]). However, in this study, Leu or Cha at R3 did not lead to significant difference in the activity against coronavirus 3CLpros ([Table 1](#tbl1){ref-type="table"}). Substitution of a benzyl group at R1 with m-Chloro benzyl group in the compounds with bisulfide adduct warhead resulted in increased activities against all 3CLpros, and this was also observed in compounds against human norovirus 3CLpros in enzyme and cell based assays ([@bib13]). We have previously reported that compounds with a bisulfite adduct warhead are converted to the precursor aldehyde form ([@bib24]), and that the bisulfite adducts and their aldehyde forms have comparable inhibitory activity against viral replication or 3CLpro ([@bib24]; [@bib25]; [@bib26]). The present study also shows the bisulfite adducts (GC551 and GC587) have similar or slightly higher activity than their aldehyde counterparts (GC543 and GC583, respectively) against all 3CLpros. However, the replacement of aldehyde or bisulfite adduct with α-ketoamide warhead, (CO)CONHcyclohexyl (GC523) or (CO)CONHcyclopropyl (GC591), at R4 resulted in a marginal (GC523) or marked reduction (GC591) in the activity against these coronavirus 3CLpros ([Table 1](#tbl1){ref-type="table"}). These results suggest these α-ketoamide groups as a warhead are generally less tolerated than aldehyde or bisulfide adduct for these coronavirus 3CLpros. Previously, we found that ketoamide groups as a warhead are associated with reduced activity against human norovirus 3CLpro ([@bib34]), but not against some picornavirus 3CLpros ([@bib22]), compared to aldehyde or bisulfite counterparts. Lastly, the importance of a carboxyl group at R2 was demonstrated by the substantial decrease in the activity against all three 3CLpros when it was changed to a sulfonyl group ([Table 1](#tbl1){ref-type="table"}).

The results from this study show that the structural requirement of 3CLpro inhibition is similar among feline, ferret and mink coronaviruses, and ferret and mink coronavirus 3CLpro share more similarity in their requirements. This close relationship between ferret and mink coronavirus 3CLpros may be explained in part by a higher amino acid homology between ferret and mink coronavirus 3CLpros (83.44--86.09%), compared to that between ferret (or mink) and feline coronavirus 3CLpros (71.52--77.81%). However, despite the differences in the activities of the compounds against these 3CLpros, it is notable that the compounds with strong inhibitory activity against feline coronavirus 3CLpro, including GC376, also exhibit potent activity against ferret and mink coronavirus 3CLpros with sub- or low micromolar IC~50~ values in the FRET assay. Among those compounds, GC587 exhibited most potent inhibition against all three 3CLpros with EC~50~ of 0.15--0.6 μM. GC587 is a variation of GC376 with modifications at R1 and R3, which is a further optimized compound toward human norovirus 3CLpro ([@bib13]).

The close relationship between feline, ferret and mink coronavirus 3CLpros is also shown by the structural models of ferret and mink coronavirus 3CLpros. These constructed 3CLpro models closely overlap with the crystal structure of feline coronavirus 3CLpro in the overall structure and in the active site topography ([Fig. 3](#fig3){ref-type="fig"}A and B and [Fig.4](#fig4){ref-type="fig"}), revealing the highly conserved nature of 3CLpro among these viruses. Previously, we identified five residues in TGEV 3CLpro that interact with GC376 in a crystallographic study of TGEV 3CLpro-GC376 complex ([@bib24]). TGEV 3CLpro has a very high amino acid homology of over 92% with feline coronavirus 3CLpro, and GC376 exhibits comparable antiviral activity against both viruses ([@bib24]). Multiple sequence alignments of 3CLpros of TGEV, feline, ferret and mink coronaviruses revealed that these amino acids, as well as the catalytic residues C144 and H41, are conserved at the same positions. When the crystal structures of TGEV and feline coronavirus 3CLpros and the structural models of ferret and mink coronavirus 3CLpros were superposed, the residues that are likely to interact with GC376 are positioned close together ([Fig. 4](#fig4){ref-type="fig"}), which may explain the potent activity of GC376 against these coronavirus 3CLpros.

One of the challenges in developing antiviral drugs for ferret and mink coronaviruses is the fastidious nature of these viruses in cell culture, which prevents the testing of the compound against virus replication in cell culture system. Therefore, we evaluated the antiviral activity of the compounds against feline coronavirus in cell culture. The antiviral activities of the compounds are generally in line with the results of the FRET assay with low cytotoxicity, which indicate they are cell-permeable and have a wide margin of *in vitro* safety. It is worth noting that several compounds, including GC376, an inhibitor with a demonstrated therapeutic potential in cats with FIP, also exhibited strong inhibitory activity against ferret and mink coronavirus 3CLpros. These results suggest that GC376 or its derivatives may have the potential to be developed as antiviral drugs for feline, ferret and mink coronavirus infections. Thus, further research on the pharmacokinetics, efficacy and safety in ferrets and minks is warranted.

In conclusion, we expressed feline, ferret and mink coronavirus 3CLpros and investigated the structure-function of a focused library of 3CLpro inhibitors against these coronavirus 3CLpros. Using the FRET assay, we identified compounds that displayed potent inhibitory activities against all three coronavirus 3CLpros. The findings in this study provide support for targeting 3CLpro for development of effective inhibitors broadly acting against feline, ferret and mink coronaviruses.
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[^1]: Current address: The Scripps Research Institute, La Jolla, CA, USA.
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[^3]: IC~50~ indicates the 50% inhibitory concentration. Values are the means and the standard error of the means from at least three independent experiments. The IC~50~ value of GC376 for feline coronavirus 3CLpro was previously reported by us ([@bib23]).

[^4]: EC~50~ and CC~50~ indicate the 50% effective concentration and 50% cytotoxicity concentration, respectively. The *in-vitro* therapeutic indices (TI) were calculated by dividing CC~50~ by EC~50~. Values are the means and the standard error of the means from at least three independent experiments. The antiviral effects of GC376, GC543 and GC551 against feline coronavirus were previously reported by us ([@bib24], [@bib25], [@bib26]), and their EC~50~ values were newly determined for this paper.
